| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |